Literature DB >> 9583866

A comparison of media supplement methods for the extended culture of human islet tissue.

D W Fraga1, O Sabek, D K Hathaway, A O Gaber.   

Abstract

BACKGROUND: The preservation of sufficient quantities of islets for human transplantation has proven to be a tenacious problem for researchers and transplant programs. Beyond the variables associated with islet procurement, there is the problem of tissue storage before transplantation. Cryopreservation has been adopted as a method for long-term islet storage that allows for recovery of viable tissue. However, there is significant tissue loss during the process and the possibility that long-term viability may be compromised. An alternate method of prolonged culture at 24 degrees C was initially introduced as a means of reducing islet antigenicity. Although successful in the short term, prolonged culture with serum-based media has also resulted in a significant loss of tissue. In this study, we report the successful use of an ITS+ Premix-supplemented serum-free media for prolonged islet culture and its comparison to fetal bovine serum-supplemented media and to cryopreservation.
METHODS: Pancreata were procured from cadaveric organ donors, and islets were isolated using our own modification of the automated method of Ricordi. Aliquots from a series of human islet isolations were cultured in parallel in (A) CMRL + ITS (serum-free media; SFM) or (B) CMRL +10% fetal bovine serum (standard media) and compared with cryopreserved and thawed tissue.
RESULTS: Our results show that SFM allows for the long-term culture of islet tissue. For time points up to 2 months, islets cultured in SFM showed recovery ratios greater than those for standard serum-supple. mented media. At 1 week and 1 month, islet recovery ratios were greater for SFM-cultured islets than for cryopreserved tissue. Viability studies confirmed that the SFM-cultured islets were able to respond to glucose stimulation (stimulation index 0.8-21.2). Additionally, in vivo results using cultured islets in a patient demonstrated good islet function, with a 1-month stimulation index of 4.02 in response to an intravenous glucose tolerance test.
CONCLUSION: We conclude that this culture modification represents a method by which functional islet tissue can be maintained in long-term culture and successfully transplanted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583866     DOI: 10.1097/00007890-199804270-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Small intestinal submucosa improves islet survival and function during in vitro culture.

Authors:  Xiao-Hui Tian; Wu-Jun Xue; Xiao-Ming Ding; Xin-Lu Pang; Yan Teng; Pu-Xun Tian; Xin-Shun Feng
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  Islet transplantation and antioxidant management: a comprehensive review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

3.  Human islet mass, morphology, and survival after cryopreservation using the Edmonton protocol.

Authors:  Priya M Miranda; Viswanathan Mohan; Sekhar Ganthimathy; Ranjit M Anjana; S Gunasekaran; Venkatachalam Thiagarajan; Thomas A Churchill; Tatsuya Kin; A M James Shapiro; Jonathan R T Lakey
Journal:  Islets       Date:  2013 Sep-Dec       Impact factor: 2.694

4.  Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.

Authors:  Gopalakrishnan Loganathan; Rajinder K Dawra; Subbiah Pugazhenthi; Zhiguang Guo; Sajjad M Soltani; Alexander Wiseman; Mark A Sanders; Klearchos K Papas; Kumaravel Velayutham; Ashok K Saluja; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

5.  Use of Mesenchymal Stem Cell-Conditioned Medium to Activate Islets in Preservation Solution.

Authors:  Naoya Kasahara; Takumi Teratani; Junshi Doi; Yuki Iijima; Masashi Maeda; Shinji Uemoto; Yasuhiro Fujimoto; Naohiro Sata; Yoshikazu Yasuda; Eiji Kobayashi
Journal:  Cell Med       Date:  2013-05-14

6.  In Vivo Bioimaging Rats for Translational Research in Cell and Tissue Transplantation.

Authors:  Takumi Teratani; Eiji Kobayashi
Journal:  Cell Med       Date:  2012-05-15

7.  Increased albumin concentration reduces apoptosis and improves functionality of human islets.

Authors:  Barbara Barbaro; Joseph Kuechle; Payam Salehi; Lisette Rodriguez; Merigeng Qi; Antonio Gangemi; Enrico Benedetti; José Oberholzer
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2008

8.  iPreP is a three-dimensional nanofibrillar cellulose hydrogel platform for long-term ex vivo preservation of human islets.

Authors:  Yi-Ju Chen; Taiji Yamazoe; Karla F Leavens; Fabian L Cardenas-Diaz; Andrei Georgescu; Dongeun Huh; Paul Gadue; Ben Z Stanger
Journal:  JCI Insight       Date:  2019-11-01

9.  Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets.

Authors:  Ajit S Narang; Kun Cheng; James Henry; Chunxiang Zhang; Omaima Sabek; Daniel Fraga; Malak Kotb; A Osama Gaber; Ram I Mahato
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

10.  Human islet function following 20 years of cryogenic biobanking.

Authors:  Jocelyn E Manning Fox; James Lyon; Xiao Qing Dai; Robert C Wright; Julie Hayward; Martijn van de Bunt; Tatsuya Kin; A M James Shapiro; Mark I McCarthy; Anna L Gloyn; Mark D Ungrin; Jonathan R Lakey; Norm M Kneteman; Garth L Warnock; Gregory S Korbutt; Raymond V Rajotte; Patrick E MacDonald
Journal:  Diabetologia       Date:  2015-05-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.